Back to Search Start Over

Exposure to airborne cadmium and breast cancer stage, grade and histology at diagnosis: findings from the E3N cohort study

Authors :
Karen Leffondré
Gianluca Severi
Aurélie M N Danjou
Delphine Praud
Floriane Deygas
Béatrice Fervers
Francesca Mancini
Lény Grassot
Amina Amadou
Elodie Faure
Thomas Coudon
Pietro Salizzoni
Centre de recherche en épidémiologie et santé des populations (CESP)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
mrt-za262
Institut National de la Santé et de la Recherche Médicale, Inserm
Agence de l'Environnement et de la Maîtrise de l'Energie, ADEME: 1306C0031
Fondation ARC pour la Recherche sur le Cancer, ARC: CAN-CAIR201601245
Ligue Contre le Cancer
Institut Gustave-Roussy
Agence de la transition écologique, ADEME
This work was supported by funding from the Oncostarter Program of the Cancéropôle Lyon Auvergne Rhône-Alpes, the French Environment and Energy Management Agency (ADEME, Grant No 1306C0031), the Regional Committee of the French League against Cancer of the Saône et Loire Region (mrt-za262) and the Auvergne Rhône-Alpes Region, and was carried out in partnership with the ARC Foundations for Cancer Research (CAN-CAIR201601245). We acknowledge the continuing support of the MGEN, the Gustave Roussy Institute and the French League Against Cancer (Ligue contre le cancer) and the contribution of the Institut National de la Santé et de la Recherche (Inserm) that runs the cohort. Amina Amadou is supported by the Regional Committee of the French League against Cancer of the Savoie Region.
Radiations : Défense, Santé, Environnement [Lyon] (Inserm UA8)
Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre Léon Bérard [Lyon]
Team MORPH3EUS (INSERM U1219 - UB - ISPED)
Bordeaux population health (BPH)
Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Laboratoire de Mecanique des Fluides et d'Acoustique (LMFA)
École Centrale de Lyon (ECL)
Université de Lyon-Université de Lyon-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon)
Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)
HAL UVSQ, Équipe
Source :
Scientific Reports, Scientific Reports, Nature Publishing Group, 2021, 11 (1), ⟨10.1038/s41598-021-01243-0⟩, Scientific Reports, 2021, 11, pp.23088. ⟨10.1038/s41598-021-01243-0⟩, Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Publication Year :
2021
Publisher :
Nature Publishing Group UK, 2021.

Abstract

Purpose Molecular and cellular studies reported a role of cadmium in risk of advanced breast cancer (BC). However epidemiological evidence is limited. Our previous study suggests that cadmium might be related to a decreased risk of ER- and ER-PR- breast tumors. In this study, we further explored the association between long-term exposure to airborne cadmium and risk of BC by stage, grade of differentiation, and histological types at diagnosis. Methods A nested case-control study of 4,401 cases and 4,401 matched controls was conducted within the French E3N cohort. A Geographic Information System (GIS) based metric was employed to evaluate outdoor airborne exposure to cadmium. Multivariable adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated using conditional logistic regression models. Results There was no statistically significant association between cadmium exposure and stage of BC in the multivariable analyses. The adjusted ORs for the fifth versus first quintile were 1.02 (95% CI: 0.83–1.25), 1.11 (95% CI: 0.84–1.49), and 0.67 (95% CI: 0.37–1.24) for stages I, II, and III-IV BC, respectively. The subgroup analyses showed no statistically significant association between cadmium exposure and grade of differentiation of BC at diagnosis. However, further analyses by histological type suggested a positive dose-response association between cadmium and risk of invasive tubular carcinoma (ITC) BC (OR for the fifth versus first quintile = 3.44 (95% CI: 1.10–10.7)). Conclusions Our results do not support the hypothesis that airborne cadmium exposure may have a role in advanced BC risk, but suggest that cadmium may be associated with an increased risk of ITC. However, these results should be considered with caution, and more epidemiological studies are needed to confirm our findings and to improve our understanding of the effects of cadmium exposure according to several clinic-pathological characteristics of BC.

Details

Language :
English
ISSN :
20452322
Volume :
11
Database :
OpenAIRE
Journal :
Scientific Reports
Accession number :
edsair.doi.dedup.....e5b4fea5b65caddd544cc1b7ce13a551